Literature DB >> 27568146

The Effect of Noncardiac and Genetic Abnormalities on Outcomes Following Neonatal Congenital Heart Surgery.

Bahaaldin Alsoufi1, Scott Gillespie2, William T Mahle2, Shriprasad Deshpande2, Brian Kogon3, Kevin Maher2, Kirk Kanter3.   

Abstract

Significant noncardiac and genetic abnormalities (NC and GA) are common in neonates with congenital heart defects. We sought to examine current-era effect of those abnormalities on early and late outcomes following cardiac surgery. The method from 2002-2012, 1538 neonates underwent repair (n = 860, 56%) or palliation (n = 678, 44%) of congenital heart defects. Regression models examined the effect of NC and GA on operative results, resource utilization, and late outcomes. Neonates with NC and GA (n = 312, 20%) had higher incidence of prematurity (21% vs 13%; P < 0.001) and weight ≤2.5kg (24% vs 12%; P < 0.001) than neonates without NC and GA (n = 1226, 80%). Although the incidence of single ventricle was comparable (34% vs 31%; P = 0.37), neonates with NC and GA underwent more palliation (52% vs 42%; P = 0.001) and subsequently had higher percentage of STAT mortality categories (Society of Thoracic Surgeons (STS) and the European Association for Cardio-thoracic Surgery (EACTS) Congenital Heart Surgery Mortality Categories) 4 and 5 procedures (78% vs 66%; P < 0.001). Adjusted logistic regression models that included disparate patient and operative variables showed that the presence of NC and GA was associated with increased unplanned reoperation (odds ratio = 1.7; 95% CI: 1.1-2.7; P = 0.03) and hospital mortality (odds ratio = 2.2; 95% CI: 1.3-3.6; P = 0.002). Adjusted linear regression models showed significant association between NC and GA and increased postoperative mechanical ventilation duration, intensive care unit, and hospital stays (P < 0.001 each). Adjusted hazard analysis showed that the presence of NC and GA was associated with diminished late survival (hazard ratio = 2.4; 95% CI: 1.9-3.1; P < 0.001) and that was evident in all subgroups of patients (P < 0.001 each). Conclusion is neonates with NC and GA commonly have associated risk factors for morbidity and mortality such as prematurity and low weight. After adjusting for those factors, the presence of NC and GA continues to have significant association with increased unplanned reoperation, hospital mortality, and resource utilization after palliative and corrective cardiac surgery. Importantly, the hazard of death in those patients continues beyond the perioperative period for at least 1 year. Our findings show that the presence of NC and GA should be emphasized during parent counseling and decision making; and underscore the need to explore strategies to improve outcomes for this high-risk population that must address perioperative care, outpatient surveillance, and management.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congenital heart disease; genetic syndromes; neonatal cardiac surgery; single ventricle

Mesh:

Year:  2015        PMID: 27568146     DOI: 10.1053/j.semtcvs.2015.10.016

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  11 in total

1.  2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates.

Authors:  Jill J Savla; Jennifer A Faerber; Yuan-Shung V Huang; Theoklis Zaoutis; Elizabeth Goldmuntz; Steven M Kawut; Laura Mercer-Rosa
Journal:  J Am Coll Cardiol       Date:  2019-09-24       Impact factor: 24.094

2.  Use of Extracorporeal Membrane Oxygenation and Mortality in Pediatric Cardiac Surgery Patients With Genetic Conditions: A Multicenter Analysis.

Authors:  Jamie M Furlong-Dillard; Venugopal Amula; David K Bailly; Steven B Bleyl; Jacob Wilkes; Susan L Bratton
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

3.  Variation in extubation failure rates after neonatal congenital heart surgery across Pediatric Cardiac Critical Care Consortium hospitals.

Authors:  Brian D Benneyworth; Christopher W Mastropietro; Eric M Graham; Darren Klugman; John M Costello; Wenying Zhang; Michael Gaies
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-04       Impact factor: 5.209

Review 4.  22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

Authors:  Carolina Putotto; Flaminia Pugnaloni; Marta Unolt; Stella Maiolo; Matteo Trezzi; Maria Cristina Digilio; Annapaola Cirillo; Giuseppe Limongelli; Bruno Marino; Giulio Calcagni; Paolo Versacci
Journal:  Children (Basel)       Date:  2022-05-25

5.  Effect of Trisomy 21 on Postoperative Length of Stay and Non-cardiac Surgery After Complete Repair of Tetralogy of Fallot.

Authors:  Eric T Purifoy; Beverly J Spray; Joe S Riley; Parthak Prodhan; Elijah H Bolin
Journal:  Pediatr Cardiol       Date:  2019-09-07       Impact factor: 1.655

6.  Prenatal Diagnosis Influences Preoperative Status in Neonates with Congenital Heart Disease: An Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  Michael D Quartermain; Kevin D Hill; David J Goldberg; Jeffrey P Jacobs; Marshall L Jacobs; Sara K Pasquali; George R Verghese; Amelia S Wallace; Ross M Ungerleider
Journal:  Pediatr Cardiol       Date:  2018-10-19       Impact factor: 1.655

7.  VSD in a kyphoscoliotic child: A perilous liaison!

Authors:  Souvik Dey; Rohan Magoon; Uma Balasubramaniam; Jasvinder K Kohli; Ramesh Kashav
Journal:  Ann Card Anaesth       Date:  2021 Oct-Dec

8.  Weight impacts 1-year congenital heart surgery outcomes independent of race/ethnicity and payer.

Authors:  Saira Siddiqui; Brett R Anderson; Damien J LaPar; David Kalfa; Paul Chai; Emile Bacha; Lindsay Freud
Journal:  Cardiol Young       Date:  2020-11-19       Impact factor: 1.093

Review 9.  Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes.

Authors:  Joshua K Meisner; Donna M Martin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-13       Impact factor: 3.359

10.  Factors That Contribute to Cost Differences Based on ICU of Admission in Neonates Undergoing Congenital Heart Surgery: A Novel Decomposition Analysis.

Authors:  Joyce T Johnson; Kirsen L Sullivan; Richard E Nelson; Xiaoming Sheng; Tom H Greene; David K Bailly; Aaron W Eckhauser; Bradley S Marino; L LuAnn Minich; Nelangi M Pinto
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.